Verbatim response from Perplexity
For menopausal hormone therapy, estrogen patches are safer than pills, primarily because they carry a significantly lower risk of dangerous blood clots and stroke.
Key Safety Differences
| Risk Factor | Estrogen Patch (Transdermal) | Estrogen Pill (Oral) |
|---|---|---|
| Blood Clots (VTE) | No significant increase in risk compared to non-users [2][5][7] | Roughly doubles the risk (relative risk ~1.6–2.0) [2][5][7] |
| Stroke Risk | No significant increase at low doses (≤50 µg) [9][10] | Modest increase in ischemic stroke risk [2][5][9] |
| Liver Processing | Bypasses the liver entirely, entering bloodstream directly [4][5][11] | Passes through liver (first-pass metabolism), triggering clotting factors [4][5][11] |
| Clot Reduction | ~33% lower risk of leg/lung clots compared to pills [1] | Higher risk; 4x more likely to cause clots vs. non-users/patches [8] |
Why the Patch is Safer
The primary safety advantage of the patch is that it delivers estradiol transdermally, bypassing the liver. Oral estrogen must pass through the liver first, which triggers the production of clotting factors (coagulation cascade) and increases clotting risk [4][5][11]. In contrast, transdermal estrogen does not alter the normal balance of coagulation factors [13].
Clinical Recommendations
- Preferred Choice: Major organizations, including the North American Menopause Society (NAMS) and the American College of Obstetricians and Gynecologists (ACOG), recommend transdermal estrogen (patches) as the first-line option for most women, especially those with cardiovascular risk factors [7][9].
- High-Risk Patients: If you have a history of blood clots, cardiovascular disease, migraines, or gallbladder issues, the patch is the clearly safer choice [7].
- Low-Risk Patients: For healthy women under 60 starting therapy within 10 years of menopause, both options are generally considered reasonable, but the patch remains preferred for its safety profile [7].
Note: This comparison refers to estrogen used for menopause (hormone replacement therapy). Contraceptive patches containing estrogen and progestin may have different risk profiles, with some studies suggesting they deliver a higher estrogen dose than contraceptive pills [6].